| 000 | 01872 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250514004827.0 | ||
| 264 | 0 | _c20011018 | |
| 008 | 200110s 0 0 eng d | ||
| 022 | _a1078-0432 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKonecny, G | |
| 245 | 0 | 0 |
_aHer-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer. _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cAug 2001 |
||
| 300 |
_a2448-57 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aBreast Neoplasms _xgenetics |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 |
_aGenetic Vectors _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xgenetics |
| 650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 1 _xanalysis |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xanalysis |
| 650 | 0 | 4 |
_aRetroviridae _xgenetics |
| 650 | 0 | 4 | _aTrastuzumab |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xanalysis |
| 700 | 1 | _aUntch, M | |
| 700 | 1 | _aArboleda, J | |
| 700 | 1 | _aWilson, C | |
| 700 | 1 | _aKahlert, S | |
| 700 | 1 | _aBoettcher, B | |
| 700 | 1 | _aFelber, M | |
| 700 | 1 | _aBeryt, M | |
| 700 | 1 | _aLude, S | |
| 700 | 1 | _aHepp, H | |
| 700 | 1 | _aSlamon, D | |
| 700 | 1 | _aPegram, M | |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 7 _gno. 8 _gp. 2448-57 |
|
| 999 |
_c11416626 _d11416626 |
||